The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma

Author: Ponziani Francesca   Ojetti Veronica   Tortora Annalisa   Di Maurizio Luca   Purchiaroni Flaminia   Gasbarrini Antonio  

Publisher: Informa Healthcare

ISSN: 1742-5255

Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.12, 2011-12, pp. : 1535-1546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract